The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS (Generic Partners Pty Ltd)
Product name
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
244 working days (255)
Active ingredients
moxonidine
Registration type
New generic medicine
Indication
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS (tablets) are indicated for the treatment of hypertension.